Form 4: Gilead Sciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Wettan Keeley M Cain, EVP Gen Counsel, Legal & Comp of Gilead Sciences, Inc., reported multiple transactions in common stock on August 10, 2026.
Summary
- Option exercise/conversion: acquired 6,002 Common Stock on August 10, 2026; holds 11,362 after (Direct).
- Tax/exercise-price withholding: disposed of 2,908 Common Stock at $133.06 ($386,938) on August 10, 2026; holds 8,454 after (Direct).
- Option exercise/conversion: disposed of 6,002 Restricted Stock Unit on August 10, 2026; holds 13,995 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Wettan Keeley M Cain — Officer (EVP Gen Counsel, Legal & Comp)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Option exercise/conversion | Common Stock | 6,002 | — | — | 11,362 |
| 2026-08-10 | Tax/exercise-price withholding | Common Stock | 2,908 | $133 | $386.9K | 8,454 |
| 2026-08-10 | Option exercise/conversion | Restricted Stock Unit | 6,002 | — | — | 13,995 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Option exercise/conversion (6,002 shares) |
| 2026-08-10 | Tax/exercise-price withholding (2,908 shares) |
| 2026-08-10 | Option exercise/conversion (6,002 shares) |
Keywords
insider transaction, Form 4, GILD, GILEAD SCIENCES, INC., neutral, Wettan Keeley M Cain
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.